Role of Stereotactic Ablative Radiotherapy in Early-Stage Lung Cancer

May 24, 2017
Alexander Louie, MD, PhD, MSc
Alexander Louie, MD, PhD, MSc

This video examines the role of radiation therapy in early-stage lung cancer and some of the data comparing stereotactic ablative radiotherapy vs surgery in these patients.

In this video Alexander Louie, MD, PhD, MSc, of the London Health Sciences Centre in Canada, discusses the role of stereotactic ablative radiotherapy (SABR) in early-stage lung cancer patients who are not eligible for surgery, some of the literature about late effects of radiotherapy, and data comparing SABR vs surgery.

Louie gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium.